Morgan Stanley Rvl Pharmaceuticals PLC Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.08 - $0.55 $76,582 - $526,504	-957,280 Reduced 96.77%	32,000 $2,000
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.17 $38,235 - $79,885	-68,278 Reduced 6.46%	989,280 $553,000
Q1 2023 May 15, 2023	SELL	$1.02 - $1.39 $39,856 - $54,314	-39,075 Reduced 3.56%	1,057,558 $1.21 Million
Q4 2022 Feb 14, 2023	SELL	$1.02 - $1.61 $78,102 - $123,279	-76,571 Reduced 6.53%	1,096,633 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$1.28 - $2.91 $60,862 - $138,367	-47,549 Reduced 3.9%	1,173,204 $2.46 Million
Q2 2022 Oct 27, 2022	SELL	$1.21 - $1.81 $64,328 - $96,226	-53,164 Reduced 4.17%	1,220,753 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$1.21 - $1.81 $64,328 - $96,226	-53,164 Reduced 4.17%	1,220,753 $1.66 Million
Q1 2022 Oct 27, 2022	BUY	$1.03 - $2.01 $54,758 - $106,859	53,164 Added 4.36%	1,273,917 $2.15 Million
Q1 2022 May 13, 2022	SELL	$1.03 - $2.01 $94,874 - $185,143	-92,111 Reduced 6.74%	1,273,917 $2.15 Million
Q4 2021 Feb 14, 2022	SELL	$0.98 - $3.06 $55,612 - $173,645	-56,747 Reduced 3.99%	1,366,028 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$2.79 - $4.19 $3.97 Million - $5.96 Million	1,422,775 New	1,422,775 $4.2 Million

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.